Recombinant Human Anthrax toxin receptor-like (ANTXRL)

What is ANTXRL and how does it relate to other anthrax toxin receptors?

ANTXRL (Anthrax toxin receptor-like) is a protein-coding gene related to the anthrax toxin receptor family. It has structural and functional similarities to ANTXR1 (Anthrax toxin receptor 1, also known as Tumor Endothelial Marker 8) and ANTXR2. ANTXRL is located on chromosome 10q11.22, with the pseudogene ANTXRLP1 located nearby. While ANTXR1 serves as a high-affinity cellular receptor for Seneca Valley Virus (SVV) and is overexpressed in over 60% of human cancers, ANTXRL's precise functions remain an active area of investigation . Unlike ANTXR2, which has a 10 times higher affinity for the protective antigen of anthrax toxin than ANTXR1 and is abundantly expressed in normal tissues, ANTXRL's binding properties and tissue distribution patterns are still being characterized .

What are the structural characteristics of ANTXRL?

While detailed structural studies specific to ANTXRL are still emerging, insights can be gained from the well-characterized ANTXR1. The ANTXR1 protein contains a von Willebrand factor A (VWA) domain similar to that found in capillary morphogenesis protein 2 (CMG2). This domain is crucial for receptor-ligand interactions and has been studied using single-particle cryo-electron microscopy analysis at near-atomic resolution . The structure reveals how ANTXR1 decorates the outer surface of the SVV capsid and interacts with multiple surface-exposed regions of viral proteins. Similar structural analyses of ANTXRL would help elucidate its binding partners and potential functions in both normal physiology and pathological conditions.

How is recombinant ANTXRL typically produced for research purposes?

Based on approaches used for related proteins, recombinant ANTXRL can be produced through several expression systems. One effective approach demonstrated with anthrax toxin receptors involves fusion with the human immunoglobulin Fc fragment. In plant-based expression systems, this strategy has yielded soluble, functional proteins that can be purified using Protein-A chromatography . Alternative expression systems include mammalian cell lines (particularly for proteins requiring mammalian post-translational modifications), bacterial systems for simpler protein fragments, and insect cell systems for higher yields of complex proteins. The choice depends on the specific research needs, including protein folding requirements, post-translational modifications, and the functional assays planned.

What is known about the genetic regulation of ANTXRL expression?

Expression quantitative trait loci (eQTL) studies have identified genetic variants that influence ANTXRL expression across various tissues. Notably, rs2999422, a single nucleotide polymorphism (SNP) located in an intron of pseudogene ANTXRLP1 near ANTXRL, functions as an eQTL for ANTXRL with a significance level of p = 1.1e-8 . Genome-wide association studies have linked this same locus (10q11.22) to facial attractiveness in females, suggesting potential pleiotropic effects of genes in this region . Transcriptome-wide association analyses have also identified SYT15 at 10q11.22, approximately 700kb upstream of ANTXRL, as significantly associated with facial attractiveness, further highlighting the complex genetic architecture of this chromosomal region .

How does ANTXRL interact with viral or bacterial components, and what are the implications for infectious disease research?

While specific interactions of ANTXRL remain under investigation, insights from ANTXR1 research provide valuable context. ANTXR1 serves as the high-affinity cellular receptor for Seneca Valley Virus (SVV), an oncolytic virus with promising results in clinical trials . The SVV-ANTXR1 complex represents a notable example of a shared receptor structure between a mammalian virus and a bacterial toxin. Structural analysis reveals that ANTXR1 decorates the outer surface of the SVV capsid and interacts with multiple viral capsid proteins (VP1, VP2, and VP3) .

For ANTXRL, similar studies examining potential interactions with viral or bacterial components would significantly advance our understanding of its biological functions. Research methodologies should include:

• Protein-protein interaction assays (pull-down assays, co-immunoprecipitation)

• Surface plasmon resonance for binding affinity measurements

• Cryo-electron microscopy to elucidate complex structures

• Cell infection assays with and without ANTXRL expression to determine its role in pathogen entry

What role might ANTXRL play in cancer biology based on the known functions of related receptors?

Given that ANTXR1 (Tumor Endothelial Marker 8) is overexpressed in over 60% of human cancers, ANTXRL may similarly have oncological significance . Research questions to explore include:

• Is ANTXRL expression altered in specific cancer types?

• Does ANTXRL function as a biomarker for cancer progression or therapy response?

• Could targeting ANTXRL provide a novel therapeutic approach for certain cancers?

Methodological approaches should include tissue microarray analysis of patient samples, correlation of expression levels with clinical outcomes, and in vitro and in vivo functional studies using gene knockdown or overexpression models. The selective expression pattern of ANTXR1 in tumor versus normal tissues has made it an attractive target for cancer therapy, and similar selective expression of ANTXRL would warrant investigation for targeted therapeutic development.

What are the key considerations for designing rigorous experiments involving recombinant ANTXRL?

Experimental design for ANTXRL research requires careful consideration of biological replication, technical replication, and potential confounding factors. As highlighted in statistical approaches for proteomics research, proper experimental design helps limit systematic errors, improves precision of statistical tests, and reduces false positives . Consider the following design elements:

Table 1: Experimental Design Considerations for ANTXRL Research

These design elements should be adapted based on the specific research question and methodological approach .

How can researchers effectively validate the specificity and functionality of recombinant ANTXRL?

Validating recombinant ANTXRL requires multiple complementary approaches:

• Biochemical Validation:

  • Western blot analysis using specific antibodies to confirm protein identity and integrity

  • Mass spectrometry to verify amino acid sequence and post-translational modifications

  • Size exclusion chromatography to assess protein oligomerization state

• Functional Validation:

  • Binding assays with potential ligands (similar to the analysis of pATR-Fc binding to anthrax PA)

  • Cell-based assays to determine if the recombinant protein retains biological activity

  • Protective capacity assessment in relevant cell models (comparable to how pATR-Fc protected J774A1 macrophage cells against anthrax toxin)

• Structural Validation:

  • Circular dichroism to assess secondary structure

  • Thermal shift assays to evaluate protein stability

  • X-ray crystallography or cryo-electron microscopy for detailed structural analysis

For each validation method, appropriate positive and negative controls should be included, and multiple batches of the recombinant protein should be tested to ensure reproducibility.

What statistical approaches are recommended for analyzing ANTXRL expression data?

Statistical analysis of ANTXRL expression data should follow rigorous approaches similar to those used in proteomics and genomics research. Key recommendations include:

• Normalization Methods:

  • Apply appropriate normalization techniques to account for technical variability

  • Consider quantile normalization for microarray data or DESeq2/EdgeR normalization for RNA-seq data

• Multiple Testing Correction:

  • Apply proper correction methods when testing multiple hypotheses

  • Options include Bonferroni correction (most stringent) or Benjamini-Hochberg procedure to control false discovery rate (FDR)

• Statistical Models:

  • Use ANOVA models with appropriate factors when comparing multiple conditions

  • Include block effects to account for experimental design factors

  • For complex designs, consider using linear mixed models

• Decision Rules:

  • Implement clear decision rules for determining significant changes

  • Consider using both statistical significance (p-value or adjusted p-value) and biological significance (effect size)

How can CRISPR/Cas9 technology be utilized to study ANTXRL function?

CRISPR/Cas9 technology offers several powerful approaches to investigate ANTXRL function:

• Gene Knockout Studies:

  • Generate ANTXRL knockout cell lines to assess phenotypic effects

  • Design guide RNAs targeting early exons to ensure complete loss of function

  • Validate knockout at both DNA (sequencing), RNA (qPCR), and protein (Western blot) levels

• Knock-in Approaches:

  • Insert fluorescent tags (GFP, mCherry) to monitor ANTXRL localization and trafficking

  • Introduce specific mutations to evaluate structure-function relationships

  • Create conditional alleles for temporal control of gene expression

• Activation/Repression Studies:

  • Use CRISPRa (activation) to upregulate endogenous ANTXRL

  • Employ CRISPRi (interference) to achieve tunable gene repression

  • Target regulatory regions to understand transcriptional control mechanisms

• High-throughput Screening:

  • Perform CRISPR screens to identify genes that interact with ANTXRL

  • Screen for synthetic lethality in cancer contexts

  • Identify modulators of ANTXRL-dependent processes

Each application requires careful guide RNA design, appropriate control selection, and thorough validation of the genetic modifications.

What approaches can be used to investigate potential protein-protein interactions involving ANTXRL?

Multiple complementary techniques should be employed to comprehensively characterize ANTXRL protein-protein interactions:

• Co-immunoprecipitation (Co-IP):

  • Use antibodies against ANTXRL or epitope-tagged versions to pull down protein complexes

  • Identify interacting partners via mass spectrometry

  • Validate key interactions with reciprocal Co-IP experiments

• Proximity-based Labeling:

  • Employ BioID or APEX2 approaches by fusing these enzymes to ANTXRL

  • Identify proximal proteins in living cells under native conditions

  • Compare interactomes across different cell types or conditions

• Yeast Two-Hybrid and Mammalian Two-Hybrid:

  • Screen for direct protein-protein interactions

  • Map interaction domains through deletion constructs

  • Validate with in vitro binding assays

• Förster Resonance Energy Transfer (FRET):

  • Visualize protein interactions in living cells

  • Assess interaction dynamics in real-time

  • Map subcellular locations of protein complexes

• Surface Plasmon Resonance (SPR):

  • Determine binding affinities and kinetics

  • Assess how mutations affect interaction properties

  • Compare ANTXRL binding properties with those of ANTXR1 and ANTXR2

How can researchers develop tissue-specific expression profiles for ANTXRL?

Developing comprehensive tissue-specific expression profiles for ANTXRL requires integrating multiple approaches:

• Transcriptomics:

  • Analyze RNA-seq data from diverse human tissues

  • Examine single-cell RNA-seq to identify cell type-specific expression

  • Investigate temporal expression patterns during development

• Proteomics:

  • Perform targeted mass spectrometry across tissue samples

  • Use antibody-based methods (immunohistochemistry, Western blot) for protein-level validation

  • Apply proximity extension assays for sensitive quantification

• Genetic Association Studies:

  • Analyze tissue-specific eQTL data to understand genetic regulation

  • Leverage the identified eQTL rs2999422 that influences ANTXRL expression

  • Consider cross-tissue transcriptome-wide association studies using methods like UTMOST

• Epigenomic Profiling:

  • Examine chromatin accessibility and histone modifications at the ANTXRL locus

  • Map tissue-specific enhancers that regulate ANTXRL expression

  • Analyze DNA methylation patterns that may influence expression

What are common challenges in expressing and purifying functional recombinant ANTXRL?

Researchers commonly encounter several challenges when working with recombinant ANTXRL:

• Protein Solubility Issues:

  • Challenge: ANTXRL may form inclusion bodies in bacterial expression systems

  • Solution: Consider fusion tags (e.g., human immunoglobulin Fc fragment) that enhance solubility, as demonstrated with related receptors

  • Alternative: Explore expression in plant-based systems, which have shown success with anthrax toxin receptors

• Proper Folding and Post-translational Modifications:

  • Challenge: Incorrect folding leading to non-functional protein

  • Solution: Expression in mammalian systems to ensure proper post-translational modifications

  • Validation: Employ circular dichroism and thermal shift assays to confirm proper folding

• Purification Complexity:

  • Challenge: Co-purification of contaminants or truncated forms

  • Solution: Multi-step purification strategies, potentially including Protein-A chromatography for Fc-fusion proteins

  • Quality control: Size exclusion chromatography as a final polishing step

• Protein Stability:

  • Challenge: Loss of activity during storage

  • Solution: Optimize buffer conditions (pH, salt, additives) and storage protocols

  • Assessment: Regular functional testing of stored protein samples

How can researchers address data inconsistencies in ANTXRL studies?

When facing data inconsistencies in ANTXRL research, consider the following approaches:

• Experimental Design Evaluation:

  • Review replication strategy (biological vs. technical replication)

  • Ensure sufficient statistical power through appropriate sample sizes

  • Implement randomization and blinding where applicable

• Method Validation:

  • Verify antibody specificity with proper controls (including ANTXRL knockout samples)

  • Confirm primer specificity for qPCR experiments

  • Validate all critical reagents independently

• Statistical Analysis Refinement:

  • Apply appropriate statistical models that account for experimental design factors

  • Consider batch effects and other confounding variables

  • Use methods that control for false discovery rate in multiple testing scenarios

• Biological Context Integration:

  • Compare results across different cell types or tissues

  • Correlate findings with known biology of related receptors (ANTXR1, ANTXR2)

  • Consider genetic variation (such as eQTLs) that might influence results

• Independent Validation:

  • Verify key findings using orthogonal methods

  • Collaborate with other laboratories for independent replication

  • Consider different experimental models to test robustness of findings

How might ANTXRL research contribute to cancer therapeutics?

ANTXRL research may contribute to cancer therapeutics in several promising directions:

• Targeted Therapy Development:
  If ANTXRL shows cancer-specific expression patterns similar to ANTXR1 (which is overexpressed in over 60% of human cancers), it could serve as a target for antibody-drug conjugates, chimeric antigen receptor (CAR) T-cell therapy, or other targeted approaches .

• Cancer Biomarker Potential:
  Expression patterns of ANTXRL across cancer types could be investigated as potential diagnostic or prognostic biomarkers, especially given the genetic associations identified at the ANTXRL locus .

• Virus-Based Therapeutic Delivery:
  Similar to how ANTXR1 functions as a receptor for Seneca Valley Virus (SVV), which has shown promise as an oncolytic agent in clinical trials, ANTXRL might potentially serve as a receptor for other viruses with selective cancer tropism .

• Immunotherapy Approaches:
  Understanding the immune system's recognition of ANTXRL in normal versus cancer tissues could inform immunotherapy strategies that exploit differences in expression or accessibility.

What emerging technologies will accelerate ANTXRL research in the coming years?

Several cutting-edge technologies are poised to advance ANTXRL research:

• Spatial Transcriptomics and Proteomics:
  These technologies allow visualization of gene and protein expression within their tissue context, potentially revealing microenvironmental factors influencing ANTXRL expression.

• Cryo-Electron Tomography:
  This advanced imaging technique could provide insights into ANTXRL's native structure within cellular membranes, complementing the structural information gained from methods like cryo-electron microscopy used for ANTXR1 .

• Advanced CRISPR Technologies:
  Techniques like base editing, prime editing, and CRISPR epigenome editing offer precise genetic manipulations to study ANTXRL function with minimal off-target effects.

• Artificial Intelligence for Protein Structure Prediction:
  Methods like AlphaFold2 can predict protein structures with unprecedented accuracy, potentially accelerating structure-function studies of ANTXRL and its interactions.

• Organoid Models:
  These 3D tissue models enable the study of ANTXRL in more physiologically relevant contexts than traditional cell culture, particularly important for understanding its role in complex tissues.

How does the genetic association between ANTXRL and facial attractiveness inform future research directions?

The unexpected genetic association between the ANTXRL locus (10q11.22) and facial attractiveness in females reveals intriguing avenues for future research :

• Pleiotropic Effects Investigation:
  Research could explore whether ANTXRL has pleiotropic effects influencing both receptor function and developmental processes related to facial features.

• Evolutionary Biology Studies:
  The negative minor allele effect observed for SNPs associated with facial attractiveness suggests potential selection pressure , warranting investigation into the evolutionary history of ANTXRL.

• Developmental Biology Research:
  Understanding how ANTXRL might influence facial development could reveal new insights into morphogenetic processes and tissue patterning.

• Hormone-Related Research:
  Given that tissues related to reproduction and hormone production were enriched for heritability of facial attractiveness , exploring ANTXRL's relationship with hormonal pathways represents an interesting research direction.

• Comparative Genomics:
  Investigating ANTXRL function across species with varying facial structures could provide evolutionary context for its potential role in facial development.

What interdisciplinary approaches would benefit ANTXRL research?

ANTXRL research would benefit from collaborative approaches spanning multiple disciplines:

• Structural Biology and Biophysics:
  Characterizing ANTXRL structure and binding properties using techniques like cryo-electron microscopy, similar to studies of the SVV-ANTXR1 complex .

• Cancer Biology and Oncology:
  Investigating ANTXRL expression and function in various tumor types, building on knowledge of ANTXR1's overexpression in cancer .

• Immunology and Infectious Disease:
  Exploring potential roles of ANTXRL in pathogen recognition or immune signaling, drawing parallels to the anthrax toxin receptor family.

• Developmental Biology and Genetics:
  Investigating the genetic association between ANTXRL and facial attractiveness to understand developmental implications .

• Computational Biology and Bioinformatics:
  Employing advanced statistical methods for analyzing large-scale transcriptomic and genomic datasets related to ANTXRL .

• Pharmaceutical Sciences and Drug Development:
  Exploring ANTXRL as a potential therapeutic target or biomarker, similar to approaches with other anthrax toxin receptors .